Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists.
Olney
J W
JW
Washington University School of Medicine, St. Louis, MO.
Price
M T
MT
Labruyere
J
J
Salles
K S
KS
Frierdich
G
G
Mueller
M
M
Silverman
E
E
D000978:Antiparkinson Agents / Q000378:metabolism / Q000494:pharmacology*; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors; D001667:Binding, Competitive; D066298:In Vitro Techniques; D016202:N-Methylaspartate; D010622:Phencyclidine / Q000378:metabolism*; D017981:Receptors, Neurotransmitter / Q000378:metabolism*; D017478:Receptors, Phencyclidine
D000978:Antiparkinson Agents; D017981:Receptors, Neurotransmitter; D017478:Receptors, Phencyclidine; D001224:Aspartic Acid; D016202:N-Methylaspartate; D010622:Phencyclidine